TNFRSF17 and neoplasm: Specifically, in this “locking on” approach, we could take advantage of the high abundance of these antigens to increase BCMA-targeting CAR-T cell dwell time on a tumor cell, thereby providing more opportunity for antigen-selective killing (Fig. 2A).